The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
INSEEGO CORP | Note 3.250%5/0 | 45782BAD6 | 9,959,413 | 24,456,000 | PRN | DFND | 0 | 0 | 24,456,000 | ||
INSEEGO CORP | COMMON | 45782B104 | 5,473,923 | 13,033,149 | SH | DFND | 0 | 0 | 13,033,149 | ||
INSEEGO CORP | COMMON | 45782B104 | 3,198,229 | 7,614,830 | SH | DFND | 1 | 0 | 0 | 7,614,830 | |
MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 136,602,679 | 3,135,966 | SH | DFND | 1 | 0 | 0 | 3,135,966 | |
Tango Therapeutics Inc. | Common | 87583X109 | 303,581 | 26,961 | SH | DFND | 1 | 0 | 0 | 26,961 |